Raymond James analyst Brian Peterson downgrades Coursera (NYSE:COUR) from Outperform to Market Perform.
Decoding 8 Analyst Evaluations For Catalyst Pharmaceuticals
In the last three months, 8 analysts have published ratings on Catalyst Pharmaceuticals (NASDAQ:CPRX), offering a diverse range…